Magnesium glycinate for women: what the studies included

Reviewed 28 sourcesPublished by PepVault

Who magnesium glycinate trials enrolled: 80% women in the sleep trial, plus PMS, menstrual migraine, pregnancy cramps and menopause, and how much women need.

Woman with a dark bob in a denim shirt picks lettuce from a raised bed by a white house
Last reviewed
Sources
28
Questions
7
Compounds
2

The short answer

Most people in the magnesium glycinate sleep trial were women: 80%, average age 41, and their insomnia eased a little. Glycinate has one trial in a women's problem, pregnancy leg cramps, where it beat placebo. The PMS, menstrual migraine, bone and hot-flash trials used other forms, and hot flashes didn't improve. Adult women need 310 to 320 mg a day from food and supplements together.

Every number checked at its primary source · · 28 sources · How we research

Evidence: Small randomized trials in women for PMS, menstrual migraine and pregnancy leg cramps, mostly with forms other than glycinate and with mixed results; one negative trial for hot flashes; reviews call the pregnancy evidence conflicting.

Woman with a dark bob in a denim shirt picks lettuce from a raised bed by a white house

Who did the magnesium glycinate trials enroll?

Mostly women. The best glycinate trial, the one most sleep articles quote, randomized 155 adults with poor sleep to 250 mg of magnesium a day as bisglycinate or placebo for four weeks1. Of the 153 analysed, 122 were women (80%), and the average age was 411. Insomnia scores fell 3.9 points on magnesium against 2.3 on placebo, a small effect1. The two threonate sleep trials look the same: 63 of 80 people were women in one2 and 63 of 100 in the other3.

TrialForm, daily magnesiumWhoWomenPregnant or breastfeeding
Schuster 20251Bisglycinate, 250 mg, 4 weeks153 adults 18 to 65 with poor sleep, average age 41122 (80%)Excluded
Hausenblas 20242L-threonate, 1 g of the salt, 21 days80 adults 35 to 55 with sleep complaints63 (79%)Excluded
Lopresti 20263L-threonate, 145 mg, 6 weeks100 adults 18 to 45 with poor sleep, average age 3763 (63%)Excluded
Abbasi 20124Oxide, 500 mg, 8 weeks46 adults with insomnia, average age 6523 (50%)Not applicable

So the glycinate result you read about is largely a result in women aged 18 to 65. None of these trials reported women separately, by cycle phase or by menopause status; the glycinate trial adjusted its analysis for sex and reported no split1. Pregnant and breastfeeding women were left out123. Which form to choose, and why, is covered at pepvault.app/guides/magnesium-glycinate-vs-citrate; the wider sleep picture is at pepvault.app/conditions/insomnia.

A smiling woman in a blue top leaning on her kitchen counter with her phone and a notebook

PepVault for iPhone

Keep your protocol in PepVault

PepVault's side-effect log takes any symptom you name, with a 1 to 5 severity and the date, so cramps, bloating or headaches can be compared cycle by cycle.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Which women's health problems has magnesium been tested for?

Four: premenstrual symptoms, menstrual migraine and period pain, leg cramps in pregnancy, and the years after menopause. Only one of these trials used glycinate. The table lists who each one enrolled.

ProblemTrialWhoForm, daily amountWhat changed
PMS moodFacchinetti 1991532 women 24 to 39Pidolate, 360 mg, in three doses, day 15 to the periodBetter total and negative-mood scores than placebo
PMS fluidWalker 1998638 womenOxide, 200 mg, 2 cyclesLess bloating, swelling and breast tenderness, in cycle 2 only
PMS anxietyDe Souza 2000744 women, average age 32Oxide, 200 mg, with or without 50 mg vitamin B6, 1 cycle eachOnly magnesium plus B6 eased anxiety symptoms
PMSFathizadeh 20108150 women 15 to 45250 mg, alone or with 40 mg B6, 2 cyclesAll groups improved; magnesium plus B6 most
Menstrual migraineFacchinetti 19911020 womenPidolate, 360 mg, day 15 to the periodFewer headache days and lower pain than placebo
Period painBenassi 1992930 women, average age 22.6Pidolate, 7 days before to day 3 of the periodDay-one pain fell over 6 cycles; no placebo
Pregnancy leg crampsSupakatisant 20151586 pregnant women, 14 to 34 weeksBisglycinate chelate, 300 mg, 4 weeksCramps halved in 86% vs 61% on placebo
Pregnancy leg crampsDahle 19951673 pregnant womenOral magnesium, 3 weeksLess cramp distress than placebo
Pregnancy leg crampsNygaard 20081745 pregnant women, 18 to 36 weeksLactate and citrate, 360 mg, 2 weeksNo difference
Hot flashesPark 201521289 women after breast cancer, 84% aged 50 or overOxide, 800 or 1,200 mg of the salt, 8 weeksNo difference; more loose stools
Bone turnoverAydin 20102220 women with postmenopausal osteoporosisCitrate, 1,830 mg, 30 daysLower PTH and a urine bone-breakdown marker than untreated controls

Amounts are as each paper states them. Where a paper gives the weight of the whole salt (oxide in the hot-flash trial, threonate), the magnesium inside is less. The bone trial's citrate figure and the pregnancy glycinate figure are not labelled either way in their abstracts152122. The PMS pidolate trial gives 360 mg given three times a day; we read it as the daily total, as in the same group's migraine trial510.

Does magnesium help PMS and period pain?

A little, in small trials of the mood and fluid symptoms. The first trial, in 32 women, found magnesium lowered the total premenstrual distress score and the negative-mood cluster within two cycles, and raised magnesium inside white blood cells while plasma levels didn't move5. A 200 mg oxide dose eased bloating, swelling and breast tenderness, but only in the second cycle6. The same group then found one cycle of oxide alone did nothing measurable; only magnesium with vitamin B6 eased anxiety symptoms, and the authors called the effect modest7. In the largest trial, 150 women, every group improved, placebo included, and magnesium with B6 did best8.

The pattern across them: effects show after a month or two, not in the first cycle, and B6 alongside often did more. For period pain there is one small trial with no placebo group, so it can't separate magnesium from expectation9.

Commonly reported: fewer cramps and less bloating in the days before a period after a couple of months of steady use, and loose stools when the amount climbs.

PepVault's side-effect log takes any symptom you name, with a 1 to 5 severity and the date, so cramps, bloating or headaches can be compared cycle by cycle. Log it in PepVault

Does magnesium help menstrual migraine?

Migraine has the strongest backing of the women's uses. In 20 women with migraine tied to their period, 360 mg of magnesium a day from day 15 of the cycle cut headache days and lowered the pain index more than placebo over two months10. In mixed groups, 600 mg a day as trimagnesium dicitrate cut attack frequency by 42% against 16% on placebo over 12 weeks in 81 adults aged 18 to 6511, and 600 mg of citrate lowered attack frequency and severity in 40 adults aged 20 to 5512; those abstracts don't give the share of women. Diarrhea came in 19% of the 600 mg group11.

The American neurology guideline rates magnesium "probably effective" for preventing migraine (Level B)13, and the European Headache Federation's 2026 expert consensus on sex-specific care lists magnesium as effective and generally safe for women of childbearing age, in pregnancy and while breastfeeding14.

Does magnesium help leg cramps in pregnancy?

The trials disagree, and this is the one place glycinate was tested directly in women. In 86 healthy pregnant women with cramps at least twice a week, 300 mg a day of magnesium bisglycinate chelate for four weeks halved cramp frequency in 86% against 61% on placebo, with no more nausea or diarrhea15. A Swedish trial of 73 women also found less cramp distress16, while a Norwegian trial of 45 women on 360 mg of lactate and citrate found no difference17.

The reviews land on the doubt. A 2021 pooled analysis of four trials and 332 pregnant women found no drop in cramp frequency19. Cochrane's 2020 review judged all five pregnancy trials (408 women) at high risk of bias, couldn't pool them, and called the evidence conflicting18. For pregnancy outcomes in general, ten trials in 9,090 women found too little good evidence that a magnesium supplement helps mother or baby20.

When to get help If you are pregnant or breastfeeding, or have kidney disease, ask your doctor or midwife before adding a magnesium supplement; the over-the-counter citrate label asks the same26.

Does magnesium help hot flashes or bone after menopause?

Not hot flashes. A small open pilot in 25 women after breast cancer saw hot-flash scores halve27, but the controlled trial that followed, 289 women, most aged 50 or over, found 800 or 1,200 mg of magnesium oxide no better than placebo over eight weeks, with more loose stools21. Its results apply to women after breast cancer, many on hormone-blocking drugs.

For bone the data are early. In 20 women with postmenopausal osteoporosis, 30 days of magnesium citrate lowered parathyroid hormone and a urine marker of bone breakdown against untreated controls22; it measured markers, not fractures or bone density. Treatment for bone loss is at pepvault.app/conditions/osteoporosis. The sleep trials enrolled women up to 651 but none reported menopause status, so no trial yet tests glycinate for menopausal sleep. For weight drugs around menopause, see pepvault.app/guides/glp-1s-and-menopause.

How much magnesium does a woman need?

The US targets, counting food, drinks and supplements together, rise in the teens and in pregnancy23:

AgeNot pregnantPregnantBreastfeeding
14 to 18360 mg400 mg360 mg
19 to 30310 mg350 mg310 mg
31 to 50320 mg360 mg320 mg
51 and over320 mg——

The upper limit is separate and counts only supplements and medicines, not food: 350 mg a day for adults in the US, set in 1997 because some people get diarrhea above it24. Europe's food safety authority sets 250 mg25. On a US Supplement Facts label the magnesium line is the magnesium itself; the salt it comes as can follow in brackets, as in "Magnesium (as magnesium bisglycinate)"28. The glycinate sleep trial (250 mg) and the pregnancy cramp trial (300 mg as stated) sat under the US limit; the 600 mg migraine trial and the hot-flash trial sat above it1111521.

Add magnesium to your plan in PepVault as an oral item and it reminds you at the time you set, logs each day, and keeps a serum magnesium result in your bloodwork. Set reminders in PepVault

Track it in the app

Sources

  1. Schuster J et al. Magnesium bisglycinate supplementation in healthy adults reporting poor sleep: a randomized, placebo-controlled trial. Nat Sci Sleep. 2025. PubMed 40918053
  2. Hausenblas HA et al. Magnesium-L-threonate improves sleep quality and daytime functioning in adults with self-reported sleep problems: a randomized controlled trial. Sleep Med X. 2024. PubMed 39252819
  3. Lopresti AL, Smith SJ. The effects of magnesium L-threonate on cognitive performance and sleep quality in adults: a randomised, double-blind, placebo-controlled trial. Front Nutr. 2026. PubMed 41601871
  4. Abbasi B et al. The effect of magnesium supplementation on primary insomnia in elderly: a double-blind placebo-controlled clinical trial. J Res Med Sci. 2012. PubMed 23853635
  5. Facchinetti F et al. Oral magnesium successfully relieves premenstrual mood changes. Obstet Gynecol. 1991. PubMed 2067759
  6. Walker AF et al. Magnesium supplementation alleviates premenstrual symptoms of fluid retention. J Womens Health. 1998. PubMed 9861593
  7. De Souza MC et al. A synergistic effect of a daily supplement for 1 month of 200 mg magnesium plus 50 mg vitamin B6 for the relief of anxiety-related premenstrual symptoms. J Womens Health Gend Based Med. 2000. PubMed 10746516
  8. Fathizadeh N et al. Evaluating the effect of magnesium and magnesium plus vitamin B6 supplement on the severity of premenstrual syndrome. Iran J Nurs Midwifery Res. 2010. PubMed 22069417
  9. Benassi L et al. Effectiveness of magnesium pidolate in the prophylactic treatment of primary dysmenorrhea. Clin Exp Obstet Gynecol. 1992. PubMed 1451282
  10. Facchinetti F et al. Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium. Headache. 1991. PubMed 1860787
  11. Peikert A et al. Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia. 1996. PubMed 8792038
  12. Köseoglu E et al. The effects of magnesium prophylaxis in migraine without aura. Magnes Res. 2008. PubMed 18705538
  13. Holland S et al. Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults. Neurology. 2012. PubMed 22529203
  14. Braca S et al. Sex-specific management of migraine: a systematic review and consensus statement from the European Headache Federation. J Headache Pain. 2026. PubMed 41998499
  15. Supakatisant C, Phupong V. Oral magnesium for relief in pregnancy-induced leg cramps: a randomised controlled trial. Matern Child Nutr. 2015. PubMed 22909270
  16. Dahle LO et al. The effect of oral magnesium substitution on pregnancy-induced leg cramps. Am J Obstet Gynecol. 1995. PubMed 7631676
  17. Nygaard IH et al. Does oral magnesium substitution relieve pregnancy-induced leg cramps? Eur J Obstet Gynecol Reprod Biol. 2008. PubMed 18768245
  18. Garrison SR et al. Magnesium for skeletal muscle cramps. Cochrane Database Syst Rev. 2020. PubMed 32956536
  19. Liu J et al. Effect of oral magnesium supplementation for relieving leg cramps during pregnancy: a meta-analysis of randomized controlled trials. Taiwan J Obstet Gynecol. 2021. PubMed 34247796
  20. Makrides M et al. Magnesium supplementation in pregnancy. Cochrane Database Syst Rev. 2014. PubMed 24696187
  21. Park H et al. North Central Cancer Treatment Group N10C2 (Alliance): a double-blind placebo-controlled study of magnesium supplements to reduce menopausal hot flashes. Menopause. 2015. PubMed 25423327
  22. Aydin H et al. Short-term oral magnesium supplementation suppresses bone turnover in postmenopausal osteoporotic women. Biol Trace Elem Res. 2010. PubMed 19488681
  23. US Departments of Agriculture and Health and Human Services. Dietary Guidelines for Americans, 2020-2025, Appendix 1, Tables A1-2 to A1-4 (from the Institute of Medicine's Dietary Reference Intakes). dietaryguidelines.gov
  24. Costello R et al. Perspective: call for re-evaluation of the tolerable upper intake level for magnesium supplementation in adults. Adv Nutr. 2023. PubMed 37487817
  25. EFSA. Overview on tolerable upper intake levels as derived by the SCF and the EFSA NDA Panel, version 11. August 2025. efsa.europa.eu
  26. Magnesium citrate oral solution (saline laxative), drug facts label. DailyMed, setid 5c5156f8-806a-ddd9-e063-6394a90afbfa. 2026. dailymed.nlm.nih.gov
  27. Park H et al. A pilot phase II trial of magnesium supplements to reduce menopausal hot flashes in breast cancer patients. Support Care Cancer. 2011. PubMed 21271347
  28. US Code of Federal Regulations. 21 CFR 101.36, Nutrition labeling of dietary supplements, paragraph (d). eCFR, current 2026. ecfr.gov

Newsletter · Weekly

The weekly peptide briefing.

New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.

We’ll email you a link to confirm. Your address is used for the briefing only. Privacy

PepVault for iPhone

Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo